Primary mediastinal large B-cell lymphoma in pregnant women
- Authors: Mangasarova I.K1, Bariakh EA1, Vorob'ev VI1, Khlavno AB1, Magomedova AU1, Shmakov RG2, Kravchenko SK1
-
Affiliations:
- ФГБУ "Гематологический научный центр" Минздрава России, Москва
- ФГБУ "Научный центр акушерства, гинекологии и перинатологии им. акад. В.И. Кулакова" Минздрава России, Москва
- Issue: Vol 86, No 7 (2014)
- Pages: 53-58
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31536
- ID: 31536
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Ia K Mangasarova
ФГБУ "Гематологический научный центр" Минздрава России, Москва
Email: v.k.jana@mail.ru
125167 Москва, Новый Зыковский пр-д, д. 4
E A Bariakh
ФГБУ "Гематологический научный центр" Минздрава России, Москва
Email: ebaryakh@gmail.com
V I Vorob'ev
ФГБУ "Гематологический научный центр" Минздрава России, Москва
Email: morela@mail.ru
A B Khlavno
ФГБУ "Гематологический научный центр" Минздрава России, Москва
A U Magomedova
ФГБУ "Гематологический научный центр" Минздрава России, Москва
Email: maminat@mail.ru
R G Shmakov
ФГБУ "Научный центр акушерства, гинекологии и перинатологии им. акад. В.И. Кулакова" Минздрава России, Москва
Email: mdshmakov@mail.ru
S K Kravchenko
ФГБУ "Гематологический научный центр" Минздрава России, Москва
Email: krav@blood.ru
References
- Surbone A., Peccatori F., Paulidis N. et al. Cancer and pregnancy. Springer-Verlag Berlin Heidelberrg 2008: 254.
- Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5: 283-289.
- Шмаков Р.Г. Беременность и лимфомы: тактика ведения, принципы диагностики и лечения. Акуш и гин 2011; 3: 86-92.
- Руководство по гематологии. Под ред. А.И. Воробьева. Т. 2. М: Ньюдиамед. 2003: 98-100.
- Pentheroudakis G., Pavlidis N. Cancer and pregnancy: poena magna, not any-more. Eur J Cancer 2006; 42: 126-140.
- Мангасарова Я.К. Молекулярная диагностика диффузной В-крупноклеточной лимфомы с первичным вовлечением лимфатических узлов средостения и первичной медиастинальной В-крупноклеточной лимфомы: Автореф. дис. ... канд. мед. наук. М 2012.
- Zinzani P.L., Martelli M., Bertini M. et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica 2002; 87: 1258-1264.
- Cheson B.D., Pfistner B., Juweid M.E. et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25 (5): 579-586.
- Cohen-Kerem R., Nulman I., Abramow-Newerly M. et al. Diagnostic radiation in pregnancy: perception versus true risks. J Obstet Gynaecol Can 2006; 28: 43-48.
- Kal H.B., Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 2005; 6: 328-333.
- Doll D.C., Ringenberg Q.S., Yarbro J.W. Antineoplastic agents and pregnancy. Semin Oncol 1989; 16: 337-346.
- Glantz J.C. Reproductive toxicology of alkylating agents. Obstet Gynecol Surv 1994; 49: 709-715.
- Germann N., Goffinet F., Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004; 15: 146-150.
- Aviles A., Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001; 2: 173-177.
- Pohlman B., Macklis R.M. Lymphoma and pregnancy. Semin Oncol 2000; 27: 657-666.
- Ortega J. Multiple agent chemotherapy including bleomycin of non-Hodgkin's lymphoma during pregnancy. Cancer 1977; 40: 2829-2835.
- Perez C.A., Amin J., Aguina L.M. et al. Primary Mediastinal Large B-Cell Lymphoma during Pregnancy. Case Rep Hematol 2012; 2012: 197347.
- Fanale M.A., Lai C.M., Rimes S.A. et al. Positive Maternal-Fetal Outcomes with Treatment of Lymphoma During Pregnancy: UT MD Anderson Cancer Center Prospective Experience. Blood Blood (ASH Annual Meeting Abstracts) 2012; 120: 3670.
- Мангасарова Я.К., Магомедова А.У., Кравченко С.К., Шмаков Р.Г. Диффузные В-крупноклеточные лимфосаркомы и беременность: терапевтическая тактика. Гематол и трансфузиол 2011; 2: 18-20.
- Kimby E., Sverrisdottir A., Elinder G. Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol 2004; 72: 292-295.
- Robinson A.A., Watson W.J., Leslie K. Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy. Lancet Oncology 2007; 8: 738-743.
- Ojeda-Uribe M., Gilliot C., Jung G. et al. Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J Perinat 2006; 26: 252-255.
- Decker M., Rothermundt C., Hollander G. et al. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol 2006; 7: 693-694.
- Lazzarino M., Orlandi E., Paulli M. et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol 1997; 15: 1646-1653.
- Mazzarotto R., Boso C., Vianello F. et al. Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience. Int J Radiat Oncol Biol Phys 2007; 68: 823-829.
- Dunleavy K. Addition of rituximab to DA-EPOCH negated need for radiotherapy in primary mediastinal B-cell lymphoma. N Engl J Med 2013; 368: 1408-1416.
- Savage K.J., Monti S., Kutok J.L. et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2008; 102: 3871-3879.
- Cairoli R., Grillo G., Tedeschi A. et al. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis. Bone Marrow Transplant 2002; 29: 473-477.
- Zinzani P.L., Zompatori M., Bendandi M. et al. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. Leuk Lymphoma 1996; 22: 131-135.
- Moskowitz C.H., Schoder H., Teruya-Feldstein J. et al. Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma. J Clin Oncol 2010; 28: 1896-1903.
- Мангасарова Я.К., Магомедова А.У., Кравченко С.К. и др. Восьмилетний опыт лечения агрессивных В-крупноклеточных лимфом средостения. Тер арх 2013; 7: 50-56.
![](/img/style/loading.gif)